(4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide
C51H73N11O6S4 — CID 155924503
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide
(4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide (PubChem CID 155924503) has the molecular formula C51H73N11O6S4 and a molecular weight of 1064.48 g/mol. Its IUPAC name is (4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide.
Molecular Properties
| Compound Name | (4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide |
|---|---|
| PubChem CID | 155924503 |
| Molecular Formula | C51H73N11O6S4 |
| Molecular Weight | 1064.48 g/mol |
| Exact Mass | 1063.46 |
| IUPAC Name | (4R,7R)-N-[(1R)-2-[2-[4-[[(2R)-2-[[(4S,7S)-8,8-dimethyl-4-[[(2R)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carbonyl]amino]-2-phenylethoxy]methyl]triazol-1-yl]ethoxy]-1-phenylethyl]-8,8-dimethyl-4-[[(2S)-2-(methylamino)propanethioyl]amino]-5-oxo-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepine-7-carboxamide |
| SMILES | CN[C@@H](C)C(=S)N[C@@H]1CCSC2CC(C)(C)[C@H](C(=O)N[C@@H](COCCn3cc(COC[C@H](NC(=O)[C@H]4N5C(=O)[C@@H](NC(=S)[C@@H](C)NC)CCSC5CC4(C)C)c4ccccc4)nn3)c3ccccc3)N2C1=O |
| InChI | InChI=1S/C51H73N11O6S4/c1-31(52-7)46(69)56-36-19-23-71-40-25-50(3,4)42(61(40)48(36)65)44(63)54-38(33-15-11-9-12-16-33)29-67-22-21-60-27-35(58-59-60)28-68-30-39(34-17-13-10-14-18-34)55-45(64)43-51(5,6)26-41-62(43)49(66)37(20-24-72-41)57-47(70)32(2)53-8/h9-18,27,31-32,36-43,52-53H,19-26,28-30H2,1-8H3,(H,54,63)(H,55,64)(H,56,69)(H,57,70)/t31-,32+,36+,37-,38-,39-,40?,41?,42-,43+/m0/s1 |
| InChIKey | RZCUZPMUQONVPL-VFGMTVNQSA-N |
| XLogP | 4.49 |
| TPSA | 196.11 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1064.48 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155924503 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.